Mice given THC-rich marijuana extract had higher brain THC levels than those given pure THC, but only CBD — not THC — reduced pain sensitivity in a nerve injury model.
Read this if you use cannabis for pain and want to understand how whole-plant extracts differ from isolated cannabinoids.
Extract > pure THCTHC-rich marijuana extract produced higher brain THC levels than pure THC alone
What the researchers found
In a pilot pharmacokinetic study, mice receiving oral THC-rich marijuana extract had higher THC levels in plasma, spinal cord, and brain compared to mice receiving pure THC alone. This suggests other compounds in the plant extract enhance THC bioavailability. However, in the spared nerve injury pain model, only oral CBD — not THC — alleviated mechanical hypersensitivity, suggesting CBD is the more promising analgesic compound from cannabis.
Why it matters
The "entourage effect" hypothesis suggests cannabis plant compounds work together. This study provides direct pharmacokinetic evidence that plant extracts deliver more THC to the brain than purified THC, while also supporting CBD as the primary pain-relieving cannabinoid.
The numbers in context
- THC levels higher in brain with THC-rich extract vs pure THC
- Only CBD (not THC) alleviated mechanical hypersensitivity
- Three formulations tested: pure THC, THC-rich extract, THC-depleted extract
- Oral administration route
How the study worked
Pilot pharmacokinetic study in mice. Compared oral pure THC vs THC-rich medical marijuana extract vs THC-depleted extract. Measured THC concentrations in plasma, spinal cord, and brain. Tested analgesic effects in the spared nerve injury (SNI) model of neuropathic pain.
Who was studied
Mice (spared nerve injury neuropathic pain model)
What this study cannot tell us
Described as a pilot study with likely small sample sizes. Mouse pharmacokinetics may not translate to humans. Only one pain model tested. Specific doses and sample sizes not detailed in abstract.
How to read the evidence
Pilot animal pharmacokinetic study. Provides preliminary evidence but is too small for definitive conclusions.
When this study was published
Published in 2023. Addresses the ongoing debate about whole-plant vs isolated cannabinoid preparations.
The bigger picture
The distinction between whole-plant cannabis and isolated cannabinoids continues to be clinically relevant. If plant compounds genuinely enhance THC bioavailability, this has implications for dosing, drug interactions, and regulatory approaches to medical cannabis products.
Questions still open
- Which specific compounds in the cannabis extract enhance THC bioavailability?
- Would the same pharmacokinetic differences be observed with inhaled vs oral administration?
- Does enhanced THC brain penetration from extracts also increase psychoactive effects?
Read the original research
Pharmacokinetics of Orally Applied Cannabinoids and Medical Marijuana Extracts in Mouse Nervous Tissue and Plasma: Relevance for Pain Treatment.
Pharmaceutics, 15(3)
Citation
Dumbraveanu, Cristiana; Strommer, Katharina; Wonnemann, Meinolf; Choconta, Jeiny Luna; Neumann, Astrid; Kress, Michaela; Kalpachidou, Theodora; Kummer, Kai K. (2023). Pharmacokinetics of Orally Applied Cannabinoids and Medical Marijuana Extracts in Mouse Nervous Tissue and Plasma: Relevance for Pain Treatment.. Pharmaceutics, 15(3). https://doi.org/10.3390/pharmaceutics15030853